Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: Potential switches in latent gene expression due to coinfection

Virology

Volumn 262, Issue 1, 1999, Pages 18-30

  Callahan, Jennifer ^a   Pai, Seema ^a   Cotter, Murray ^a   Robertson, Erle S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; LATENT MEMBRANE PROTEIN 1;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL IMMORTALIZATION; CONTROLLED STUDY; CROSS REACTION; EPSTEIN BARR VIRUS; GENE EXPRESSION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LYMPHOBLASTOID CELL LINE; LYMPHOMA CELL LINE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; LANA;

EID: 0033568360     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9876     Document Type: Article

References (56)

1. Aiyar A., Tyree C., Sugden B. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J. 17:1998;6394-6403.
2. Arvanitakis L., Mesri E. A., Nador R. G., Said J. W., Asch A. S., Knowles D. M., Cesarman E. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood. 88:1996;2648-2654.
3. Aster J., Robertson E. S., Hasserjian R. P., Turner J. R., Kieff E., Sklar J. Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jk or nuclear localization sequences retain the ability to associate with RBP-Jk and activate transcription. J. Biol. Chem. 272:1997;11336-11343.
4. Boyle M. J., Sculley T. B., Penny R., Sewell W. A., Tschuchnigg M., Berger M. F., Cooper D. A. The role of Epstein-Barr virus subtypes in human immunodeficiency virus- associated lymphoma. Leuk Lymphoma. 10:1993a;17-23.
5. Boyle M. J., Sewell W. A., Sculley T. B., Apolloni A., Turner J. J., Swanson C. E., Penny R., Cooper D. A. Subtypes of Epstein-Barr virus in human immunodeficiency virus- associated non-Hodgkin lymphoma. Blood. 78:1991;3004-3011.
6. Boyle M. J., Vasak E., Tschuchnigg M., Turner J. J., Sculley T., Penny R., Cooper D. A., Tindall B., Sewell W. A. Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: Association between B-type EBV and immunocompromised [see comments]. Blood. 81:1993b;468-474.
7. Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas [see comments]. N. Engl. J. Med. 332:1995a;1186-1191.
8. Cesarman E., Moore P. S., Rao P. H., Inghirami G., Knowles D. M., Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood. 86:1995b;2708-2714.
9. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma [see comments]. Science. 266:1994;1865-1869.
10. Farrell P. Epstein-Barr virus. O'Brien S. J. Genetic Maps. 1993;Cold Spring Harbor Laboratory, Cold Spring Harbor.
11. Finke J., Rowe M., Kallin B., Ernberg I., Rosen A., Dillner J., Klein G. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J Virol. 61:1987;3870-3878.
12. Flore O., Rafii S., Ely S., O'Leary J. J., Hyjek E. M., Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma- associated herpesvirus. Nature. 394:1998;588-592.
13. Fruehling S., Swart R., Dolwick K. M., Kremmer E., Longnecker R. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J. Virol. 72:1998;7796-7806.
14. Gahn T. A., Sugden B. Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation. J. Virol. 67:1993;6379-6386.
15. Gahn T. A., Sugden B. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69:1995;2633-2636.
16. Ganem D. KSHV and Kaposi's sarcoma: The end of the beginning. Cell. 91:1997;157-160.
17. Gessain A. Human herpesvirus 8 and associated diseases: Kaposi's sarcoma, body cavity based lymphoma and multicentric Castleman disease: Clinical and molecular epidemiology. Bull. Acad. Natl. Med. 181:1997;1023-1034.
18. Gessain A., Sudaka A., Briere J., Fouchard N., Nicola M. A., Rio B., Arborio M., Troussard X., Audouin J., Diebold J. Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: Is there any relevant association in non-human immunodeficiency virus-infected patients? [letter; comment]. Blood. 87:1996;414-416.
19. Henle G., Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer. 17:1976;1-7.
20. Henle G., Henle W., Clifford P., Diehl V., Kafuko G. W., Kirya B. G., Klein G., Morrow R. H., Munube G. M., Pike P., Tukei P. M., Ziegler J. L. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J. Natl. Cancer Inst. 43:1969;1147-1157.
21. Horenstein M. G., Nador R. G., Chadburn A., Hyjek E. M., Inghirami G., Knowles D. M., Cesarman E. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood. 90:1997;1186-1191.
22. Izumi K. M., Kieff E. D. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-Kappa B. Proc. Natl. Acad. Sci. USA. 94:1997;12592-12597.
23. Kaye K. M., Izumi K. M., Kieff E. D. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA. 90:1993;9150-9154.
24. Kedes D. H., Ganem D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J. Clin. Invest. 99:1997;2082-2086.
25. Kedes D. H., Lagunoff M., Renne R., Ganem D. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J. Clin. Invest. 100:1997;2606-2610.
26. Kieff E. Epstein-Barr virus and its replication. Fields K. D., Howley P. Fields Virology. 1996;Lippincott-Raven, Philadelphia.
27. Kieff E., Hennessy K., Fennewald S., Matsuo T., Dambaugh T., Heller M., Hummel M. Biochemistry of latent Epstein-Barr virus infection and associated cell growth transformation. IARC Sci. Publ. 60:1985;323-339.
28. Mann K. P., Staunton D., Thorley-Lawson D. A. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J. Virol. 55:1985;710-720.
29. Maunders M. J., Petti L., Rowe M. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c- specific monoclonal antibody. J. Gen. Virol. 75:1994;769-778.
30. Miller G., Heston L., Grogan E., Gradoville L., Rigsby M., Sun R., Shedd D., Kushnaryov V. M., Grossberg S., Chang Y. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol. 71:1997;314-324.
31. Miller G., Lisco H., Kohn H. I., Stitt D., Enders J. F. Establishment of cell lines from normal adult human blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody. Proc. Soc. Exp. Biol. Med. 137:1971;1459-1465.
32. Miller G., Robinson J., Heston L., Lipman M. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. Proc. Natl. Acad. Sci. USA. 71:1974;4006-4010.
33. Miller G., Shope T., Lisco H., Stitt D., Lipman M. Epstein-Barr virus: Transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc. Natl. Acad. Sci. USA. 69:1972;383-387.
34. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:1995;389-399.
35. Neipel F., Albrecht J. C., Fleckenstein B. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: Determinants of its pathogenicity. J. Virol. 71:1997;4187-4192.
36. Pallesen G., Hamilton-Dutoit S. J., Rowe M., Young L. S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease [see comments]. Lancet. 337:1991;320-322.
37. Pearson G. R., Vroman B., Chase B., Sculley T., Hummel M., Kieff E. Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. J. Virol. 47:1983;193-201.
38. Picchio G. R., Sabbe R. E., Gulizia R. J., McGrath M., Herndier B. G., Mosier D. E. The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft. Virology. 238:1997;22-29.
39. Raab M. S., Albrecht J. C., Birkmann A., Yaguboglu S., Lang D., Fleckenstein B., Neipel F. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J. Virol. 72:1998;6725-6731.
40. Renne R., Lagunoff M., Zhong W., Ganem D. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J. Virol. 70:1996;8151-8154.
41. Rettig M. B., Ma H. J., Vescio R. A., Pold M., Schiller G., Belson D., Savage A., Nishikubo C., Wu C., Fraser J., Said J. W., Berenson J. R. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients [see comments]. Science. 276:1997;1851-1854.
42. Rickinson A., Keiff E. D. Epstein-Barr virus. Fields K. D., Howley P. Fields Virology. 1996;Lippincott-Raven, Philadelphia.
43. Robertson E. S. The Epstein-Barr virus EBNA3 protein family as regulators of transcription. Epstein-Barr Virus Rep. 4:1997;143-150.
44. Robertson E., Kieff E. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs. J. Virol. 69:1995a;983-993.
45. Robertson E. S., Kieff E. D. Genetic analysis of Epstein-Barr virus in B lymphocytes. Epstein-Barr Virus Rep. 2:1995b;73-80.
46. Robertson E. S., Ooka T., Kieff E. D. Epstein-Barr virus vectors for gene delivery to B lymphocytes. Proc. Natl. Acad. Sci. USA. 93:1996;11334-11340.
47. Robertson E. S., Tomkinson B., Kieff E. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro. J. Virol. 68:1994;1449-1458.
48. Russo J. J., Bohenzky R. A., Chien M. C., Chen J., Yan M., Maddalena D., Parry J. P., Peruzzi D., Edelman I. S., Chang Y., Moore P. S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA. 93:1996;14862-14867.
49. Sample J., Brooks L., Sample C., Young L., Rowe M., Gregory C., Rickinson A., Kieff E. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc. Natl. Acad. Sci. USA. 88:1991;6343-6347.
50. Shibata D., Weiss L. M., Hernandez A. M., Nathwani B. N., Bernstein L., Levine A. M. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus [see comments]. Blood. 81:1993;2102-2109.
51. Szekely L., Chen F., Teramoto N., Ehlin-Henriksson B., Pokrovskaja K., Szeles A., Manneborg-Sandlund A., Lowbeer M., Lennette E. T., Klein G. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line [published erratum appears in J. Gen .Virol.79(11), 2875, 1998]. J. Gen. Virol. 79:1998;1445-1452.
52. Tissier F., de Pinieux G., Thiounn N., Merran S., Gessain A., Tulliez M., Vieillefond A. Castleman's disease and chromophobe carcinoma of the kidney. An incidental association. Ann. Pathol. 18:1998;429-431.
53. Tomkinson B., Kieff E. D. Use of second-site hamologons recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. J. Virol. 66:1992;2893-2903.
54. Tomkinson B., Robertson E. S., Keiff E. D. Epstein-Barr Virus nuclear proteins EBNAS3A and EBNA3C one essential for B-lymphocyte growth transformation. J Virol. 67:1993;2014-2052.
55. Wilson J. B., Bell J. L., Levine A. J. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 15:1996;3117-3126.
56. Young L. S., Lau R., Rowe M., Niedobitek G., Packham G., Shanahan F., Rowe D. T., Greenspan D., Greenspan J. S., Rickinson A. B. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol. 65:1991;2868-2874.